Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
16,681,212
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
1,416,355
-
Shares change
-
+64,713
-
Total reported value, excl. options
-
$5,449,280
-
Value change
-
+$229,489
-
Number of buys
-
11
-
Number of sells
-
-5
-
Price
-
$3.84
Significant Holders of Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) as of Q3 2023
17 filings reported holding COYA - Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2023.
Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,416,355 shares
of 16,681,212 outstanding shares and own 8.49% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (535,794 shares), GREENLIGHT CAPITAL INC (468,067 shares), Worth Venture Partners, LLC (134,006 shares), CM Management, LLC (100,000 shares), GEODE CAPITAL MANAGEMENT, LLC (87,065 shares), PRELUDE CAPITAL MANAGEMENT, LLC (35,770 shares), BlackRock Inc. (22,019 shares), Mirador Capital Partners LP (15,913 shares), VANGUARD GROUP INC (14,204 shares), and Tower Research Capital LLC (TRC) (2,101 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.